ONCC PRACTICE TESTS (OCN - CARE CONTINUUM) Exam | Questions & 100% Correct Answers (Verified) | Latest Update | Grade A+

Which of the following is an advantage of an implanted vascular access device over a tunneled central venous catheter? Decreased risk of infection Short-term use Low cost of insertion Unlimited ability to access Correct Answer: Decreased risk of infection Answer: Implanted ports have a lower risk of infection than tunneled central venous catheters. Reference: Camp-Sorrell, D., & Matey, L. (Eds.). (2017). Access device standards of practice for oncology nursing. Pittsburgh, PA: Oncology Nursing Society, p. 67. The nurse teaches a patient that the purpose of a living will is to: 2 establish the patient's desires for care prior to a life-threatening illness. make final decisions regarding treatment until disease progression. acknowledge the risks and limitations of recommended therapies. appoint a surrogate to make medical decisions. Correct Answer: establish the patient's desires for care prior to a life-threatening illness. Answer: Living wills are designed to determine the care that a patient is agreeable to receive or not receive in the event of a terminal illness. Reference: Eggert, J. (Ed.). (2017). Cancer basics (2nd ed.). Pittsburgh, PA: Oncology Nursing Society, p. 655(t). Within which timeframe will chemotherapy-induced alopecia normally begin after receiving a first treatment? 2 weeks 24 hours 1 month 3 3 months Correct Answer: 2 weeks Answer: Hair loss from chemotherapy usually begins two weeks after beginning treatment. Reference: Eggert, J. (Ed.). (2017). Cancer basics (2nd ed.). Pittsburgh, PA: Oncology Nursing Society, p. 360. A patient with breast cancer who received cyclophospamide five years ago reports a new onset of bruising and fatigue. The nurse suspects: a secondary leukemia. liver failure. leukoencephalopathy. cardiomyopathy. Correct Answer: a secondary leukemia. Answer: The risk of secondary leukemia increases with the use of alkylating agents. Reference: Polovich, M., Olsen, M., & LeFebvre, K. (Eds.). (2014). Chemotherapy and biotherapy guidelines and recommendations for practice (4th ed.). Pittsburgh, PA: Oncology Nursing Society, p. 446(t)